Abstract
Objective
To investigate if size measurements of liver observations is more variable in the arterial phase as suggested by LI-RADS and assess potential higher instability in categorization in this particular phase. Secondarily, to assess inter- and intra-reader agreement for size across phases.
Materials and methods
Patients with liver cirrhosis who underwent multi-arterial phase MRI between 2017 and 2018 were retrospectively selected. Three radiologists measured liver observations in each phase, independently, in a random order. Mean size between early and late arterial phases (AP), 2, 3 and 10 min delay and the number of observations crossing the LI-RADS size thresholds (10 and 20 mm) per phase were compared using McNemar’s test. Reader agreement was evaluated using intraclass correlation coefficient (ICC) and bootstrap-based comparisons. Bonferroni’s correction was applied to pairwise comparisons.
Results
94 observations (LR-3, LR-4, LR-5, and LR-M) were included. Mean sizes (mm) were late AP: 19.9 (95% CI 17.2, 24.2), 2 min delay: 19.8 (95% CI 17.1, 24.0), 3 min delay: 19.8 (95% CI 17.2, 24.0), 10 min delay: 20.2 (95% CI 17.5, 24.5) (p = 0.10–0.88). There was no difference between phases in number of observations that could have changed category due to variability in size (p = 0.546–1.000). Inter- and intra-reader agreement was excellent (ICC = 0.952–0.981).
Conclusion
Measurements of focal liver observations were consistent across all post-contrast imaging phases and we found no higher instability in LI-RADS category in any particular phase. Inter- and intra-reader agreement for size was excellent for each phase. Based on these findings, size measurement could be allowed on any post-contrast phase, including the arterial phase, if deemed appropriate by the radiologist.
Similar content being viewed by others
Data availability
All data included in the manuscript is available at request to the corresponding author.
Abbreviations
- LI-RADS:
-
Liver imaging reporting and data system
- HCC:
-
Hepatocellular carcinoma
- AP:
-
Arterial phase
- mHAP:
-
Multi-hepatic arterial phase
References
Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019 Jan 1;156(2):477-91.
Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology. 2016 Apr 1;150(4):835-53.
Available at: https://optn.transplant.hrsa.gov/media/1200/optn_policies.pdf [Accessed Dec 10, 2019]
Ayuso C, Rimola J, Vilana R, et al. Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines. Eur J Radiol. 2018 Apr 1;101:72-81.
Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018 Aug 1;68(2):723-50.
Chernyak V, Fowler KJ, Kamaya A, et al. Liver Imaging Reporting and Data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology. 2018 Sep 25;289(3):816-30.
Available at: https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/LI-RADS [accessed Dec 10, 2019]
Francis IR, Cohan RH, McNulty NJ, et al. Multidetector CT of the liver and hepatic neoplasms: effect of multiphasic imaging on tumor conspicuity and vascular enhancement. AJR Am J Roentgenol. 2003 May;180(5):1217-24.
Yacoub JH, Elsayes KM, Fowler KJ, et al. Pitfalls in liver MRI: Technical approach to avoiding misdiagnosis and improving image quality. J Magn Reson Imaging. 2019 Jan;49(1):41-58.
Min JH, Kim YK, Kang TW, et al. Artifacts during the arterial phase of gadoxetate disodium-enhanced MRI: multiple arterial phases using view-sharing from two different vendors versus single arterial phase imaging. Eur Radiol. 2018 Aug 1;28(8):3335-46.
Chernyak V, Fowler KJ, Heiken JP, Sirlin CB. Use of gadoxetate disodium in patients with chronic liver disease and its implications for liver imaging reporting and data system (LI‐RADS). J Magn Reson Imaging. 2019 May;49(5):1236-52.
Saranathan M, Rettmann DW, Hargreaves BA, Clarke SE, Vasanawala SS. Differential subsampling with cartesian ordering (DISCO): A high spatio‐temporal resolution dixon imaging sequence for multiphasic contrast enhanced abdominal imaging. J Magn Reson Imaging. 2012 Jun;35(6):1484-92.
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977 Mar 1:159-74.
Fowler KJ, Potretzke TA, Hope TA, Costa EA, Wilson SR. LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma. Abdom Radiol. 2018 Jan 1;43(1):149-57.
van Lunenburg JT, Tripathi V, Chan VS, et al. Sequence and Observer Variability in Gadoxectic Acid-Enhanced MRI Lesion Measurements in Hepatocellular Carcinoma. Acad Radiol. 2019 Jul 17.
Chernyak V, Flusberg M, Law A, Kobi M, Paroder V, Rozenblit AM. Liver Imaging Reporting and Data System: discordance between computed tomography and gadoxetate-enhanced magnetic resonance imaging for detection of hepatocellular carcinoma major features. J Comput Assist Tomogr. 2018 Jan 1;42(1):155-61.
Schellhaas B, Hammon M, Strobel D, et al. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS. Eur Radiol. 2018 Oct 1;28(10):4254-64.
Ehman EC, Behr SC, Umetsu SE, et al. Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas. Abdom Radiol. 2016 May 1;41(5):963-9.
Davenport MS, Khalatbari S, Liu PS, et al. Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging. Radiology. 2014 Feb 18;272(1):132-42.
Wald C, Russo MW, Heimbach JK, Hussain HK, Pomfret EA, Bruix J. New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology. 2013 Feb;266(2):376-82.
Funding
The authors state that this work has not received any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors listed have no financial interests or relationships to disclose with regard to the subject matter of this manuscript.
Ethical approval
The institutional ethics review board approved this cross-sectional, single-center, retrospective study and waived the informed consent requirement. Data were collected and handled in accordance with the Health Insurance Portability and Accountability Act.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cunha, G.M., Kwon, H., Wolfson, T. et al. Examining LI-RADS recommendations: should observation size only be measured on non-arterial phases?. Abdom Radiol 45, 3144–3154 (2020). https://doi.org/10.1007/s00261-020-02490-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-020-02490-x